Healthy Living/WellnessJury Favors Merck Over Gilead In Hepatitis C Drug Patent Dispute A federal jury favored Merck & Co. over Gilead Sciences Inc. in a high-profile lawsuit involving patents for new hepatitis C drugs. Merck sued Gilead for using sofosbuvir in hepatitis drugs Sovaldi and Harvoni.by Rhodi Lee
Healthy Living/WellnessGilead Pricing Strategy For Hepatitis C Drug Sovaldi Focused on Maximizing Profits Not Patients: Reportby Katrina Pascual
Healthy Living/WellnessNurse Giving Workplace Flu Shots Used Same Syringe On 67 Peopleby Katherine Derla
Healthy Living/WellnessWhite House Under Pressure To Promote Better Access For Hepatitis C Drugsby Jill Arce
Healthy Living/WellnessMiami Blood Bank Closed By FDA Due To Numerous HIV-Related Violationsby Dianne Depra
Healthy Living/WellnessAccess To Breakthrough Hepatitis C Drugs May Be Hampered By Restrictions: Studyby Rhodi Lee
Healthy Living/WellnessChina Rejects Patent Application Of Gilead For $1,000 A Day Hepatitis C Drug Sovaldiby Rhodi Lee
Healthy Living/WellnessHepatitis C Cases In Appalachian States Soar: What You Should Know About Hep Cby Dianne Depra
Healthy Living/WellnessGilead Fights For Hepa C Drug Patents: Activists Concerned About Drug Accessibilityby Dianne Depra
Healthy Living/WellnessIndiana Emergency Needle Exchange Program Is Expiring: Bad News For HIV Outbreakby Ted Ranosa